Fig. 4 DATS inhibites Wnt/β-catenin pathway in colorectal CSCs.
The tumorspheres enriched from SW480 and DLD-1 were treated with different concentrations of DATS for 5 days, a, b SW480 and DLD-1 colonspheres were treated with DATS for 5 days. The expression levels of the critical molecules in Wnt/β-catenin pathway were determined by qRT-PCR (a) and Western blotting (b), respectively. c-f SW480 and DLD-1 sphere-forming cells were cultured with 40 µM DATS in the presence or absence of 20 mM LiCl for 5 days, and the protein levels for Wnt/β-catenin pathway were detected by Western blotting (c). d The images of tumorspheres were obtained. Bar 100 µm. e Western blot analysis of colorectal CSCs markers. f SW480 cells were transfected with control vector or β-catenin plasmids, and then treated with or without DATS (40 µM) for 3 days. The levels for β-CATENIN, CD133 and ALDH1 were detected by Western blotting. Data are expressed as mean ± SD of three independent experiments. *P < 0.05, **P < 0.01 compared with control group. # P < 0.05, ## P < 0.01 compared with 40 µM DATS group
